Tags

Type your tag names separated by a space and hit enter

A New Symptom of COVID-19: Loss of Taste and Smell.
Obesity (Silver Spring). 2020 05; 28(5):848.O

Links

Publisher Full Text
ncbi.nlm.nih.gov
doi.org
PMC Free PDF

Authors+Show Affiliations

Gautier JF
Department of Diabetes and Endocrinology, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France. INSERM UMRS 1138, Centre de Recherches des Cordeliers, Paris, France.
Ravussin Y
Department of Endocrinology, Metabolism & Cardiovascular System, Faculty of Science & Medicine, University of Fribourg, Fribourg, Switzerland.

MeSH

BetacoronavirusCOVID-19Coronavirus InfectionsFemaleHumansOlfaction DisordersPandemicsPneumonia, ViralSARS-CoV-2SmellTasteTaste Disorders

Pub Type(s)

Letter

Language

eng

PubMed ID

32237199

Clinical Trial Links

Natural Killer Cells and Bortezomib to Treat Cancer

Citation

Gautier, Jean-François, and Yann Ravussin. "A New Symptom of COVID-19: Loss of Taste and Smell." Obesity (Silver Spring, Md.), vol. 28, no. 5, 2020, p. 848.
Gautier JF, Ravussin Y. A New Symptom of COVID-19: Loss of Taste and Smell. Obesity (Silver Spring). 2020;28(5):848.
Gautier, J. F., & Ravussin, Y. (2020). A New Symptom of COVID-19: Loss of Taste and Smell. Obesity (Silver Spring, Md.), 28(5), 848. https://doi.org/10.1002/oby.22809
Gautier JF, Ravussin Y. A New Symptom of COVID-19: Loss of Taste and Smell. Obesity (Silver Spring). 2020;28(5):848. PubMed PMID: 32237199.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A New Symptom of COVID-19: Loss of Taste and Smell. AU - Gautier,Jean-François, AU - Ravussin,Yann, Y1 - 2020/04/01/ PY - 2020/03/23/received PY - 2020/03/23/accepted PY - 2020/4/3/pubmed PY - 2020/4/28/medline PY - 2020/4/3/entrez SP - 848 EP - 848 JF - Obesity (Silver Spring, Md.) JO - Obesity (Silver Spring) VL - 28 IS - 5 SN - 1930-739X UR - https://www.unboundmedicine.com/medline/citation/32237199/A_New_Symptom_of_COVID_19:_Loss_of_Taste_and_Smell_ L2 - https://doi.org/10.1002/oby.22809 DB - PRIME DP - Unbound Medicine ER -